Breaking Patrick Mahomes’ Preseason Status Uncertain Amid Recovery, Team Eyes Other Quarterbacks Trump Claims Voter Anger Directed at Republicans, Not Him, Amid Shifting Polls Pope Francis to Visit Argentina Amid Economic Hardship Ohio State Coach Ryan Day Addresses Offensive Line Concerns Ahead of 2026 Season Former Federal Prosecutor Sues Justice Department Over Termination, Citing First Amendment Rights

Friday August 7, 2026

Reporter

Outlook Therapeutics, Inc.

2Articles Published

5Communities Covered

Published Articles

Press Release

Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026

Aug 6

Press Release

Outlook Therapeutics Announces LYTENAVA™ FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet AMD

Jul 24